Socially Assistive Robots for Interaction With Older Adults With Dementia
NCT ID: NCT04384978
Last Updated: 2024-07-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2020-01-12
2022-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ryan Companion Robot for Assisting Elderly People With Alzheimer's Disease
NCT05052866
Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy
NCT05178992
Effects of a Robot on Physical and Psychosocial Outcomes of Persons With Dementia and Their Social Environment at Home
NCT03818217
SimpleC Wellness Platform With Social Robot Interaction (Long-term)
NCT05599503
Measuring the Impact of a Socially Assistive Robot
NCT04848155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Control Group: Group 2 users will play solitary games (word puzzles) and activities but will have no interaction with Ryan.
Play Solitary Games Without a Social Robot
Control Group: Group 2 will play solitary games (e.g., word puzzles) and activities but will have no interaction with Ryan.
Active Group
Active Group: Group 1 users will play games with and administered by Ryan, 2-3 times a week and 30-minutes per day.
Play Serious Games with a Social Robot (Ryan)
Active Group: Game play and physical activities with Ryan, a socially assistive robot developed at DreamFace Technologies,LLC.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Play Serious Games with a Social Robot (Ryan)
Active Group: Game play and physical activities with Ryan, a socially assistive robot developed at DreamFace Technologies,LLC.
Play Solitary Games Without a Social Robot
Control Group: Group 2 will play solitary games (e.g., word puzzles) and activities but will have no interaction with Ryan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Early Alzheimer's disease and related dementia diagnosed by a qualified provider
* Saint Louis University Mental Status (SLUMS) score between 10 and 25
* Resident of assisted living facility for at least one month prior and for the duration of the study
* Deemed conditioned enough to participate in physical activities after a wellness check
* Verbal skill to interact
* Participant or Legal decision
Exclusion Criteria
* Diagnosed with severe dementia or memory loss
* Acute physical illness that impairs ability to participate
* Patients with serious comorbidity, tumors and other diseases casually related to cognitive impairment
* History of alcohol or drug abuse, head trauma, psychoactive substance use and other causes of memory impairment
* Significant sensory impairment
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
DreamFace Technologies, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammad Mahoor
Founder and CEO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eaton Senior Communities
Lakewood, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.